Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome
Objectives: To determine the usefulness of myeloperoxidase in discriminating between patients with acute coronary syndrome and patients with chest pain by other causes. Methods: The study included all patients over 18 years of age who come consecutively to the emergency department from September 201...
Main Authors: | Pilar Calmarza, Carlos Lapresta, María Martínez, Raquel Lahoz, Javier Povar |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2018-12-01
|
Series: | Archivos de Cardiología de México |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1405994017301210 |
Similar Items
-
Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome
by: Sumitra Govindarajan, et al.
Published: (2016-08-01) -
Copeptin, myeloperoxidase and pro-adrenomedullin for acute coronary syndrome in patients with chronic kidney disease
by: Jen Heng Pek, et al.
Published: (2019-09-01) -
Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes
by: Valentina Loria, et al.
Published: (2008-01-01) -
Severity evaluation value of serum myeloperoxidase content detection in patients with acute coronary syndrome
by: Zhao-Di Xie, et al.
Published: (2017-01-01) -
The role of myeloperoxidase as a diagnostic and prognostic factor in cardiovascular pathology (acute coronary syndrome)
by: M. P. Kopytsia, et al.
Published: (2021-10-01)